scispace - formally typeset
T

Takahiro Nakajima

Researcher at Chiba University

Publications -  263
Citations -  7009

Takahiro Nakajima is an academic researcher from Chiba University. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 39, co-authored 230 publications receiving 6221 citations. Previous affiliations of Takahiro Nakajima include University Health Network.

Papers
More filters
Journal ArticleDOI

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

TL;DR: The discovery of two secondary mutations within the kinase domain of EML4-ALK in tumor cells isolated from a patient during the relapse phase of treatment with an ALK inhibitor are reported.
Journal ArticleDOI

Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.

TL;DR: Compared to CT and PET, EBUS-TBNA has a high sensitivity as well as specificity for mediastinal and hilar lymph node staging in patients with lung cancer.
Journal ArticleDOI

Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis

TL;DR: Endobronchial ultrasound-guided transbronchia needle aspiration proved to be a safe procedure with a high yield for the diagnoses of sarcoidosis.
Journal ArticleDOI

The Utility of Sonographic Features During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Lung Cancer: A Standard Endobronchial Ultrasound Image Classification System

TL;DR: Sonographic features of lymph nodes based on the new EBUS imaging classification may be helpful in the prediction of metastasis in patients with lung cancer and to establish a standard endobronchial ultrasound (EBUS) image classification system.
Journal ArticleDOI

Assessment of Epidermal Growth Factor Receptor Mutation by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

TL;DR: EGFR mutation can easily be detected in metastatic lymph nodes sampled by EBUS-TBNA and may provide us with indications for EGFR-TKI therapy in the near future.